Aurobindo Pharma Limited has incorporated a new wholly owned subsidiary company named 'Auropharm Overseas Limited' in India. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of these regulations.
Key Details of the Subsidiary
- Name: Auropharm Overseas Limited
- Incorporation Date: August 13, 2026
- Country of Incorporation: India
- Relationship: Wholly owned subsidiary of Aurobindo Pharma Limited
- Industry: Pharmaceuticals
Transaction Details
- Nature of Acquisition: Incorporation of new subsidiary
- Percentage of Shareholding Acquired: 100%
- Consideration: 100% cash subscription to share capital
- Cost of Acquisition: Initial subscription of ₹10,00,000 divided into 1,00,000 equity shares of ₹10 each
- Promoter Interest: No promoter or promoter group members have any interest in the transaction, confirmed to be at arm's length
Purpose and Operations
- Objects: To undertake manufacturing and marketing operations in India and foreign countries
- Regulatory Approvals: No governmental or regulatory approvals required for the incorporation
- Timeframe for Completion: Not applicable (already incorporated)
Historical Information
- This is a newly incorporated company, therefore no historical financial information (including turnover for the last 3 years) is available